deltatrials
Completed PHASE3 INTERVENTIONAL 4-arm NCT03806530

DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS)

DIalysis Symptom COntrol-Restless Legs Syndrome Trial (DISCO-RLS Trial): A Randomized Controlled Trial

Sponsor: Population Health Research Institute

Updated 8 times since 2019 Last updated: Sep 19, 2022 Started: May 1, 2019 Primary completion: Dec 14, 2021 Completion: Jul 19, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on End Stage Renal Disease and Restless Legs Syndrome, this trial is completed. The trial is conducted by Population Health Research Institute and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2019 – ~Apr 2019 · 59 days · monthly snapshotNot Yet Recruiting~Apr 2019 – ~Dec 2019 · 8 months · monthly snapshotNot Yet Recruiting~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotRecruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotRecruiting~Apr 2021 – ~Sep 2022 · 17 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE3

    Status: RecruitingCompleted

  4. Apr 2021 — Sep 2022 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE3

Show 3 earlier versions
  1. Dec 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

  2. Apr 2019 — Dec 2019 [monthly]

    Not Yet Recruiting PHASE3

  3. Feb 2019 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Population Health Research Institute
Data source: Population Health Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .